CRP and infection: Other CRP lowering approaches, such as apheresis, have also shown that the therapeutic targeting of CRP does not appear to increase the risk of infection (Torzewski et al, 2020, 2021, 2022; Ries et al, 2021; Ringel et al, 2021; Schumann et al, 2021).